Dolutegravir, abacavir and lamivudine as HIV therapy

Author： Fernandez-Montero Jose Vicente Barreiro Pablo Labarga Pablo De Mendoza Carmen Soriano Vicente

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.7, 2014-05, pp. : 1051-1057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Fixed-dose combination of abacavir, lamivudine and zidovudine for HIV therapy

By Milinkovic Ana Mallolas Josep

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 23-30

Future Medicine

Access to resources Recommend Favorite

Abacavir/lamivudine and tenofovir/emtricitabine similar for HIV-1

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Abacavir plus Lamivudine: A Review of their Combined Use in the Management of HIV Infection

By Toni M. Dando Lesley J. Scott

Drugs, Vol. 65, Iss. 2, 2005-01 ,pp. : 285-302

Adis International

Access to resources Recommend Favorite

Abacavir/lamivudine fixed-dose combination tablet for the treatment of HIV-1 infection

By Taylor Clare L Wilkins Edmund GL

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 11-21

Future Medicine

Access to resources Recommend Favorite

Abacavir and lamivudine combination

By Somboonwit Charurut Kurtyka Don Paula Velez Ana

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1599-1606

Informa Healthcare

Access to resources Recommend Favorite